theory clinical_39_6
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Has :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  TTKInhibitor :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Block :: "event ⇒ bool"
  Of :: "entity ⇒ entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  Effects :: "entity ⇒ bool"
  EffectiveIn :: "entity ⇒ entity ⇒ bool"
  With :: "entity ⇒ entity ⇒ bool"
  LeadsTo :: "event ⇒ event ⇒ bool"
  NecessaryFor :: "event ⇒ event ⇒ bool"
  Contribute :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  Effectiveness :: "entity ⇒ bool"

(* Explanation 1: This patient has an activating mutation in CTNNB1, and TTK inhibitors block the activity of CTNNB. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Patient x ∧ Mutation y ∧ CTNNB1 z ∧ Has e1 ∧ Agent e1 x ∧ Agent e1 y ∧ In y z ∧ TTKInhibitor x ∧ Activity y ∧ Block e2 ∧ Agent e2 x ∧ Agent e2 y ∧ Of y z"

(* Explanation 2: Blocking the activity of CTNNB1 is necessary to reduce the effects of activating mutations in CTNNB. *)
axiomatization where
  explanation_2: "∀x y z e1 e2. Activity x ∧ CTNNB1 y ∧ Mutation z ∧ Block e1 ∧ Agent e1 x ∧ Of x y ⟶ (Reduce e2 ∧ Agent e2 x ∧ Agent e2 z ∧ In z y)"

(* Explanation 3: Reducing the effects of activating mutations in CTNNB1 is necessary for TTK inhibitors to be effective in patients with such mutations. *)
axiomatization where
  explanation_3: "∀x y z e1 e2. Effects x ∧ Mutation y ∧ CTNNB1 z ∧ Reduce e1 ∧ Agent e1 x ∧ In y z ⟶ (TTKInhibitor x ∧ EffectiveIn x y ∧ Patient y ∧ With y z)"

(* Explanation 4: If a patient has an activating mutation in CTNNB1 and TTK inhibitors block the activity of CTNNB1, then blocking the activity of CTNNB1 leads to reducing the effects of these mutations, which is necessary for making TTK inhibitors effective in this patient. *)
axiomatization where
  explanation_4: "∀x y z e1 e2 e3 e4. Patient x ∧ Mutation y ∧ CTNNB1 z ∧ Has e1 ∧ Agent e1 x ∧ Agent e1 y ∧ In y z ∧ TTKInhibitor x ∧ Activity y ∧ Block e2 ∧ Agent e2 x ∧ Agent e2 y ∧ Of y z ⟶ (Block e3 ∧ Agent e3 y ∧ LeadsTo e3 e2 ∧ NecessaryFor e3 e4 ∧ EffectiveIn x y)"

(* Explanation 5: Blocking the activity of CTNNB1 directly contributes to the effectiveness of TTK inhibitors in patients with activating mutations in CTNNB. *)
axiomatization where
  explanation_5: "∀x y z e1 e2. Activity x ∧ CTNNB1 y ∧ Mutation z ∧ Block e1 ∧ Agent e1 x ∧ Of x y ⟶ (Contribute e2 ∧ Directly e2 ∧ To e2 x ∧ In x y ∧ With y z)"

theorem hypothesis:
  assumes asm: "TTKInhibitor x ∧ Patient y"
  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)
  shows "∃x y. TTKInhibitor x ∧ Patient y ⟶ EffectiveIn x y"
proof -
  (* From the premise, we have known information about TTK inhibitors and the patient. *)
  from asm have "TTKInhibitor x ∧ Patient y" by simp
  (* Explanation 1 provides that if a patient has an activating mutation in CTNNB1 and TTK inhibitors block the activity of CTNNB1, then blocking the activity leads to reducing the effects of these mutations. *)
  (* Explanation 4 states that this reduction is necessary for making TTK inhibitors effective in this patient. *)
  (* We have logical relations: Implies(And(A, B), Implies(C, D)) and Implies(D, E). *)
  (* Therefore, if blocking the activity of CTNNB1 leads to reducing the effects, then TTK inhibitors are effective. *)
  then have "EffectiveIn x y" sledgehammer
  then show ?thesis <ATP>
qed

end
